High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease.

Sanai, Faisal M

High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease. [electronic resource] - Liver international : official journal of the International Association for the Study of the Liver 08 2018 - 1395-1401 p. digital

Publication Type: Journal Article; Observational Study

1478-3231

10.1111/liv.13674 doi


2-Naphthylamine
Adult
Anilides--therapeutic use
Antiviral Agents--therapeutic use
Carbamates--therapeutic use
Cohort Studies
Cyclopropanes
Drug Therapy, Combination
Female
Hepacivirus--genetics
Hepatitis C, Chronic--complications
Humans
Lactams, Macrocyclic
Liver Cirrhosis--virology
Macrocyclic Compounds--therapeutic use
Male
Middle Aged
Proline--analogs & derivatives
Registries
Renal Insufficiency, Chronic--complications
Ribavirin--therapeutic use
Ritonavir--therapeutic use
Saudi Arabia
Sulfonamides--therapeutic use
Sustained Virologic Response
Uracil--analogs & derivatives
Valine